---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-044802"
form_type: "8-K"
ticker: "ENSC"
cik: "0001716947"
company_name: "Ensysce Biosciences, Inc."
filed_at: "2026-09-29T12:31:00+00:00"
generated_at: "2026-10-12T13:43:13.850444+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Ensysce Biosciences amends Series C preferred certificate to remove holder cash redemption provision

## Summary
- On September 25, 2026, Ensysce Biosciences amended the Series C Certificate of Designation to remove Section 6.5.3 and related references.
- Section 6.5.3 had allowed holders to redeem Series C Preferred for cash after stockholder approval of conversion if Common Stock delivery failed, at then-current fair value.
- The amendment was effective upon filing; a Certificate of Correction had been filed on August 6, 2026 after the original August 5, 2026 Series C designation.
- Ensysce filed the amendment as Exhibit 3, and CEO Lynn Kirkpatrick signed the report on September 29, 2026.
- The Series C Preferred Stock and Common Stock each have par value $0.0001 per share; Common Stock trades as ENSC on Nasdaq.

## SEC filing metadata
- accession: 0001493152-26-044802
- form_type: 8-K
- ticker: ENSC
- cik: 0001716947
- company_name: Ensysce Biosciences, Inc.
- filed_at: 2026-09-29T12:31:00+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1716947/000149315226044802/0001493152-26-044802-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1716947/000149315226044802/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-044802
- JSON: https://secwatch.observer/filing/0001493152-26-044802.json
- Plain text: https://secwatch.observer/filing/0001493152-26-044802.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.